American International Group’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-22,574
| Closed | -$342K | – | 3036 |
|
|
2022
Q3 | $342K | Buy |
22,574
+651
| +3% | +$7.57K | ﹤0.01% | 1824 |
|
|
2022
Q2 | $164K | Buy |
21,923
+906
| +4% | +$6.38K | ﹤0.01% | 2322 |
|
|
2022
Q1 | $191K | Sell |
21,017
-1,479
| -7% | -$11.4K | ﹤0.01% | 2270 |
|
|
2021
Q4 | $158K | Sell |
22,496
-674
| -3% | -$7.05K | ﹤0.01% | 2501 |
|
|
2021
Q3 | $264K | Sell |
23,170
-551
| -2% | -$8.05K | ﹤0.01% | 2260 |
|
|
2021
Q2 | $380 | Buy |
23,721
+2,340
| +11% | +$40.1K | ﹤0.01% | 2101 |
|
|
2021
Q1 | $382 | Buy |
21,381
+57
| +0.3% | +$985 | ﹤0.01% | 1985 |
|
|
2020
Q4 | $288 | Sell |
21,324
-612
| -3% | -$7.39K | ﹤0.01% | 2079 |
|
|
2020
Q3 | $258K | Sell |
21,936
-499
| -2% | -$6.08K | ﹤0.01% | 1985 |
|
|
2020
Q2 | $331K | Sell |
22,435
-2,555
| -10% | -$37.8K | ﹤0.01% | 1819 |
|
|
2020
Q1 | $337K | Sell |
24,990
-1,442
| -5% | -$27.4K | ﹤0.01% | 1626 |
|
|
2019
Q4 | $639K | Sell |
26,432
-223
| -0.8% | -$4.62K | ﹤0.01% | 1562 |
|
|
2019
Q3 | $512K | Sell |
26,655
-186
| -0.7% | -$4.26K | ﹤0.01% | 1645 |
|
|
2019
Q2 | $793K | Buy |
26,841
+4,156
| +18% | +$160K | ﹤0.01% | 1442 |
|
|
2019
Q1 | $1.08M | Sell |
22,685
-734
| -3% | -$32.3K | ﹤0.01% | 1279 |
|
|
2018
Q4 | $845K | Sell |
23,419
-182
| -0.8% | -$8.54K | ﹤0.01% | 1362 |
|
|
2018
Q3 | $1.45M | Buy |
23,601
+426
| +2% | +$27.4K | ﹤0.01% | 1212 |
|
|
2018
Q2 | $1.56M | Buy |
23,175
+1,422
| +7% | +$79.6K | 0.01% | 1125 |
|
|
2018
Q1 | $1.18M | Sell |
21,753
-569
| -3% | -$31.8K | ﹤0.01% | 1181 |
|
|
2017
Q4 | $1.33M | Buy |
22,322
+557
| +3% | +$33.8K | ﹤0.01% | 1192 |
|
|
2017
Q3 | $1.06M | Buy |
21,765
+2,928
| +16% | +$160K | ﹤0.01% | 1313 |
|
|
2017
Q2 | $990K | Buy |
18,837
+1,374
| +8% | +$64K | ﹤0.01% | 1295 |
|
|
2017
Q1 | $792K | Buy |
17,463
+3,615
| +26% | +$161K | ﹤0.01% | 1317 |
|
|
2016
Q4 | $524K | Sell |
13,848
-37
| -0.3% | -$1.4K | ﹤0.01% | 1605 |
|
|
2016
Q3 | $524K | Buy |
13,885
+21
| +0.2% | +$463 | ﹤0.01% | 1581 |
|
|
2016
Q2 | $244K | Buy |
13,864
+1,082
| +8% | +$17.5K | ﹤0.01% | 2004 |
|
|
2016
Q1 | $155K | Buy |
12,782
+666
| +5% | +$10.5K | ﹤0.01% | 3014 |
|
|
2015
Q4 | $295K | Sell |
12,116
-8
| -0.1% | -$187 | ﹤0.01% | 2464 |
|
|
2015
Q3 | $216K | Sell |
12,124
-25,044
| -67% | -$454K | ﹤0.01% | 2746 |
|
|
2015
Q2 | $656K | Buy |
37,168
+30,461
| +454% | +$558K | ﹤0.01% | 1933 |
|
|
2015
Q1 | $210K | Sell |
6,707
-32
| -0.5% | -$928 | ﹤0.01% | 2904 |
|
|
2014
Q4 | $197K | Sell |
6,739
-261
| -4% | -$6.62K | ﹤0.01% | 2955 |
|
|
2014
Q3 | $145K | Buy |
7,000
+127
| +2% | +$2.5K | ﹤0.01% | 3242 |
|
|
2014
Q2 | $170K | Buy |
6,873
+1,618
| +31% | +$28K | ﹤0.01% | 3136 |
|
|
2014
Q1 | $111K | Buy |
5,255
+126
| +2% | +$2.55K | ﹤0.01% | 3341 |
|
|
2013
Q4 | $92.1K | Buy |
+5,129
| New | +$66.8K | ﹤0.01% | 3391 |
|
American International Group's AERI Position: Q4 2022 in Review
American International Group sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 22,574 shares — an estimated $342K sold.
American International Group first reported a position in AERI in Q4 2013 and held it in 36 quarters. The position peaked at $1.56M in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- American International Group reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- American International Group sold 22,574 Aerie Pharmaceuticals shares in Q4 2022, an estimated $342K.
- American International Group first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 36 quarters.
- American International Group's Aerie Pharmaceuticals position peaked at $1.56M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on American International Group's 13F filing for Q4 2022, filed 10 Feb 2023.